| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 30.0K | $44.4K | - | |
| CFO | 15.0K | $22.2K | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 4,250 | $16.89 | $71,774.85 | -2.1% | |
| Jun 1, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 4,250 | $18.67 | $79,359.83 | -2.1% | |
| May 17, 2016 | Watler Peter K. | Chief Technical Officer | Sale+OE | 12,000 | $20.00 | $240,000.00 | -100% | |
| May 2, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 4,250 | $19.20 | $81,591.76 | -1.0% | |
| May 2, 2016 | Watler Peter K. | Chief Technical Officer | Sale+OE | 21,493 | $26.89 | $578,038.00 | -100% | |
| Apr 1, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 4,250 | $21.36 | $90,762.79 | -1.0% | |
| Mar 2, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 6,500 | $15.29 | $99,397.19 | -1.5% | |
| Feb 5, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 2,000 | $15.02 | $30,040.40 | -0.9% | |
| Jan 4, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 4,250 | $21.47 | $91,252.02 | -0.9% | |
| Dec 1, 2015 | Herman Alan C. | Chief Scientific Officer | Sale+OE | 11,333 | $29.49 | $334,196.56 | -2.6% |